Events

Below is a list of events where CELT researchers and staff are presenting CELT research, or events that CELT is endorsing.

The event logo is the words

ARIA visit to the University of Liverpool

1-2.30pm (GMT), Friday 26 September 2025, Liverpool UK

Hosted by the Centre of Excellence for Long-acting Therapeutics, join Programme Director Brian Wang and his team for a session, at the Leggate Lecture Theatre on September 26th. Learn about their newly launched programme thesis, Sustained Viral Resilience.

You might find the session especially valuable if:

You conduct antiviral research and have ideas for a proposal
You work in synthetic biology, materials chemistry, or systems biology and are interested in forming teams for the programme
You work on platforms, models, or tools that could broadly accelerate innate vaccine development
You help bring innovative medicines from bench-to-patient, whether that be through clinical trial design, patient engagement, or regulatory science innovation

Find out more, and register, on the ARIA event page.

Unlocking Access to Individual-Level Pharmacokinetic Data via PKRxiv

12-1pm (BST), 30 September 2025, online webinar.

Join Dr Adeniyi Olagunju, from the Perinatal Pharmacology group, for an insightful webinar on how to access individual-level pharmacokinetic (PK) data and associated covariates through PKRxiv — a purpose-built repository for PK data.

Find out more about the learning outcomes and how to register via the event page.

An image of Cape Town coast line with text to the left saying:

INHSU 2025: International Conference on Health and Hepatatis in Substance Users

14-17 October 2025, CapeTown South Africa

This year's conference around health and hepatitis in substance users that meaningfully involves people who use drugs is back in its home city for the first time in five years. Shatyam Issur, a LONGEVITY project LAT CAB member, will be presenting a talk on some exciting community engagement research from LONGEVITY.

The presentation title is 'Preferences and feasibility of long-acting technologies for the treatment of hepatitis C virus: A survey of patients in diverse low- and middle-income countries'.

For more information including booking, please head to the INHSU 2025 conference page.

CELT's Community of Practice for long-acting therapeutics for maternal and paediatric health

22 October 2025, online webinar

Community of Practice context

Significant gaps currently exist in the development of new medicines for women of child-bearing age and children, compared with the general adult population. This gap could expand further with new treatment modalities like long-acting therapeutics. Additionally, the extent of breastfed infant exposure through breast milk is largely unknown.

The overarching aim of this community of practice (funded by global health agency Unitaid) is to catalyse the development and availability of long-acting therapeutics of value for maternal and paediatric health globally, including in low- and middle- income countries.

This will be achieved through the following specific objectives:

Engaging relevant stakeholders in academia, clinical practice, pharmaceutical industry, regulators, women and patient groups
Synthesise evidence-based perspectives on best practices for long-acting therapeutics
Disseminate outputs from the community of practice for uptake by the wider community.

There are 9 meetings for the community of practice in 2025 (2 full community of practice meetings online (one has already occurred), 1 in person workshop and 6 shorter webinars (one has already occurred)). The next online session will be held on Wednesday 22 October, 2025.

To join the Community of Practice and attend this meeting, please fill in this Expression of Interest form to receive an invite link.

We will use this Events page to keep you updated on the remaining events, so please check back. Members are welcome to join the community of practice at any point.

Securing the future: Shaping the UK strategy on long-acting therapeutics

10am-4pm (GMT), 6 November 2025, Liverpool UK

HALo is dedicated to advancing a national strategy that recognises the economic and healthcare potential of long-acting therapeutics in the UK. We aim to accelerate long-acting therapeutics by tackling key technical challenges, engaging patients, raising awareness across clinical and public groups, and establishing a national manufacturing strategy - from pre-clinical proof-of-concept to UK-wide GMP manufacturing - while creating a regulatory environment that supports rapid clinical evaluation and market access.

This event will bring together stakeholders from across the long-acting therapeutics landscape to explore current barriers and opportunities in manufacturing and adoption of LA medicines.

Confirmed speakers include representatives from:

HALo
The NHS (on patient and clinician adoption)
GSK (on their experience in an approved long-acting therapy, cabenuva)
Upperton (a leading CDMO)
Regulatory experts to ensure a well-rounded and forward-looking discussion.

Your insights would be invaluable to this conversation, and we would be delighted to have you, or a member of your team join us.

Contact the HALo team to register or for further information.

AAPS 2025 PHarmSCi 360

9-12 November 2025, San Antonio USA

This four day conference is organised around six core areas; Discovery and basic research; Preclinical, clinical and translational sciences; Bioanalytics; Manufacturing and analytical characterization; Formulation and delivery; Professional advancement track.

Five members of CELT will be presenting at the conference.

Find out more, including how to register, on the PHarmSCi 360 event page.

Previous events

LEAP | New Approaches to Bioequivalence Assessment and Generic Approvals for Long Acting/Extended Release Antiretroviral Formulations

Find all the recordings from the workshop talks here.

LEAP | Long-acting Tuberculosis Drug Development Workshop 2024 - 15 April 2024

Watch CELT co-Director Prof. Andrew Owen's presentation here.

Find all the recordings from the workshop here.

19th Residential Course on Clinical Pharmacology and Antiretrovirals - 17-19 January 2024

Download the presentation decks here